课题基金 / 基金详情

PHARMACOLOGY AGENDA

PHARMACOLOGY AGENDA
药理学议程
批准号:
5205123
负责人:
MICHAEL M LEDERMAN
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

MICHAEL M LEDERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A pediatric component the Case Western Reserve University ACTU is proposed. The component will append to a highly successful adult ACTU (1st or 2nd quartile), which will provide the infrastructure to enable efficient enrollment of children at low additional cost. Though no funding has been available for pediatric protocols in the past, three patients have been successfully entered and maintained on pediatric trials. The rapidly expanding population of HIV-infected children in Cleveland ensures future candidates for enrollment. Subjects will be drawn from patients referred by community pediatricians and obstetricians to the Special Immunology Unit, the multi-disciplinary AIDS specialty clinic at University Hospitals of Cleveland. In addition, referrals will be made from two large HIV screening programs for urban minority pregnant women; both of these screening programs are administered by the pediatric component director, insuring expeditious referral. The total predicated referrals from these programs will equal 6 children with confirmed infection, and 25-48 seropositive maternal-infant pairs over the first twelve months, enabling enrollment of a minimum of six patients the first year, and 12/yr by the end of the funding period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADULT AIDS CLINICAL RESEARCH
  • 批准号:
    3727024
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    MICHAEL M LEDERMAN
  • 依托单位:
RIFAMPIN, CIPROFLAXACIN, CLOFAZIMINE, ETHAMBUTOL, & AMIKACIN IN HIV+ INDIVIDUALS
PROCYSTEINE IN PATIENTS INFECTED WITH HIV--EFFECTS ON LEVELS OF GLUTATHIONE
CORE--ADVANCED TECHNOLOGY LABORATORIES
  • 批准号:
    5205127
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    MICHAEL M LEDERMAN
  • 依托单位:
    --
海外基金